TRK Inhibition in TRK Fusion–Positive Lung Cancers

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: A Q&A With Dr. Edgardo S. Santos Castillero

CheckMate 568: Efficacy and Biomarker Analysis for Nivolumab and Ipilimumab in NSCLC

Smoking Ban in Austria Passed After Years of Political Wrangling

A Balancing Act: Managing Patients’ Expectations

STARS Patient Research Advocate Training Program Seeks Patients and Caregivers

Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC

Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies

From Patient to Patient Research Advocate: The STARS Journey

Letter to the Editor: Patient-Driven Research

Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy

Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data